MALOFF is a medication commonly used for the prevention and treatment of malaria, a serious and sometimes fatal disease transmitted through the bite of an infected Anopheles mosquito. It contains two active ingredients, atovaquone and proguanil hydrochloride, which work together to inhibit the reproduction of the malaria parasite in the human body, thereby helping to prevent the onset of the disease in individuals who are at risk or to treat those who have already been infected. MALOFF is typically available in tablet form and is prescribed by healthcare professionals based on the specific needs and health conditions of the patient, as well as the geographical area of travel, due to varying resistance patterns of malaria parasites around the world.